Skip to main content

Biomedical, Clinical & Life Sciences

Arizona Trauma-Informed Substance Use Prevention Program (TISUPP)

Limit: 1 // Tickets Available: 0

A. Dixon-Kleiber (Gila County Cooperative Extension)


Limiting Language
This solicitation only allows one application per eligible entity (amendment to RFGA forthcoming). 

Summary
Governor Katie Hobbs’ Office of Youth, Faith and Family, issues this Request for Grant Application (RFGA) Solicitation concerning the Arizona Trauma-Informed Substance Use Prevention Program (TISUPP) in accordance with A.R.S. §41-2701. Applications for this program will only be accepted through the State’s web-based grants management system, Euna Grants (formerly eCivis). The deadline for submission of an application in Euna will be on or before 11:59 PM (Arizona time) on June 15, 2026. It is anticipated that the results of this solicitation will be announced on September 15, 2026.

NIFA Equipment Grants Program

Request Ticket // Limit: 2 // Tickets Available: 2

Limiting Language
For FY 2026, an eligible institution may only submit two applications to this program as a lead institution and only one award will be made per lead institution. Prospective applicants/project directors are advised to contact their institutional office of research regarding processes used to select proposals for submission. To receive an award in FY 2026, the lead institution may not have received more than two (2) USDA-NIFA EGP awards as lead institution in the previous two (2) EGP funding cycles.

Executive Summary 
The Equipment Grants Program (EGP) serves to increase access to shared-use special purpose equipment/instruments for fundamental and applied research for use in the food and agricultural sciences programs at institutions of higher education, including State Cooperative Extension Systems. The program seeks to strengthen the quality and expand the scope of fundamental and applied research at eligible institutions by providing them with opportunities to acquire one shared-use piece of equipment/instrument that supports their research, research training, and extension goals that may be too costly and/or not appropriate for support through other NIFA grant programs. The program emphasizes shared-use instrumentation that will enhance the capabilities of researchers, educators, and extension specialists both within and outside the proposing organization. 

Funding Type
External Deadline
6/25/2026

Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (S15 Clinical Trial Not Allowed)

The University of Arizona is not eligible for this funding opportunity

NIGMS will co-fund applications from higher education institutions that award undergraduate (B.S. or B.A.) and/or graduate degrees in biomedical sciences and have received no more than $6 million dollars per year (total costs) from NIH Research Project Grants (RPGs) in each of the preceding two fiscal years, calculated using NIH RePORTER, at the time of the application.  Applications to be considered must support research aligned with the NIGMS mission. Applications for research capacity building in Institutional Development Award (IDeA)-eligible states will be considered.  


 

Coccidioidomycosis Collaborative Research Centers (P01 Clinical Trial Not Allowed)

Limit: 1 // Tickets Available: 0

J. Galgiani (Valley Fever Center for Excellence)

Limiting Language
Only one application per institution (normally identified by having a unique entity identifier (UEI) number or NIH IPF number) is allowed.

Funding Opportunity Purpose
The purpose of the notice of funding opportunity (NOFO) is to solicit applications for a Coccidioidomycosis Collaborative Research Centers (CCRC) program. This new initiative will establish highly collaborative, multi-disciplinary, research teams to conduct translational and clinical research to support the development of a Valley fever vaccine as outlined in NIAID’s Strategic Plan for Research to Develop a Valley fever Vaccine.

 


 


 

FY 2025 Fire Prevention and Safety (FP&S) Grants Program

Limit: 1 // Tickets Available: 0 

J. Burgess (Community, Environment and Policy)

Limiting Language
Eligible applicants may submit only one application for each eligible activity under the FP&S Grant Program (one application under the FP&S Activity and/or one application under the R&D Activity). Applications for both activities  may include up to three projects. Eligible Applicants interested in applying under both activities must submit two separate applications – one for each activity. The application questions included in the FP&S Activity are different from those in the R&D Activity application. Submissions of duplicate applications may be disqualified.  

Purpose
FP&S Grant Program supports fire departments and non-profit organizations for fire prevention programs and firefighter health and safety research and development. The FP&S Grant Program is separated into the following two activities: Fire Prevention and Safety (FP&S) and Research and Development (R&D). Using a competitive process that is informed by fire service subject matter experts, the Federal Emergency Management Agency (FEMA) awards grants in both activities to applicants whose requests best address the priorities of the FP&S Grant Program. 

NSF X-Labs: Scientific Instrumentation for Sensing and Imaging (Topic 2)

Institutionally Coordinated - contact RDS if you are interested in this funding opportunity // Limit: 2 (lead organization)

SUBJECT TO CHANGE STATEMENT: The terms of this funding opportunity are actively under ORP review and the competition is thus subject to change. The solicitation indicates that academic institutions are not the end goal for this funding. 

Limiting Language 
An eligible organization can submit a maximum of two Written Proposals per Topic Announcement for Phase 0 as a lead organization. Senior/Key Personnel may be listed on a maximum of one Written Proposal per Topic Announcement.

Topic Description

Every revolution in science has been preceded by a revolution in what we can measure, from the telescope to modern Magnetic Resonance Imaging (MRI) machines. Today, the frontier is starved for radically new modalities for sensing and imaging. We cannot watch a non-crystalline enzyme work at atomic resolution, probe the full dynamics of a working synapse, or identify the most reactive surface defect structures on advanced catalytic materials.

NSF X-Labs in this Topic will target specific platform technologies in sensing, imaging and supporting technologies that will form the basis for revolutionary new capabilities in scientific discovery and technology sectors. Teams might, for example, draw on quantum sensing, artificial intelligence (AI)-driven computational imaging, adaptive AI-based sensing algorithms, and/or entirely new modalities to redefine what we consider knowable. 

Examples of relevant, currently unmet R&D challenges may include, but are not limited to: detection of molecular-scale single-reaction events across timescales of femtoseconds to seconds; MRI-free deep-tissue imaging; non-destructive biomolecule microscopy at exquisite resolution; high-sensitivity quantum sensors suitable for operation in a variety of environments; instruments intentionally engineered for next-generation AI training pipelines; and sensors to resolve whole-brain activity at cellular resolution across long timescales. 

An NSF X-Labs Mission in this Topic must be transformative, accelerating breakthrough R&D in scientific instrumentation towards creating or reshaping new lines of research and technologies. Successful teams will overcome technical barriers facing sensing and imaging, develop platform technologies, demonstrate measurable impact on the U.S. science and technology landscape, and position their technologies for widespread use and investment in research and/or other sectors. 

Examples of challenges not considered in scope for this Topic include computational or software solutions without practical integration into an instrumentation system, development of technologies where the impact is narrow and not widely deployable, fundamental research without potential for application in platform technologies, incremental advancement of the state of the art, or advancement of technologies that are already appropriately developed to the point of full-scale commercialization.

Full sponsor guidelines are linked here. 

Upcoming Webinars
Thursday, May 28, 1–2 p.m. Eastern Daylight Time (EDT)
Introduction to NSF X-Labs Funding Opportunity – Scientific Instrumentation for Sensing and Imaging
Register for the May 28 webinar.

Tuesday June 23, 2:30–3:30 p.m. EDT
Q&A for NSF X-Labs – Scientific Instrumentation for Sensing and Imaging
Register for the June 23 Q&A session.

National Center for Construction Safety and Health Research and Translation (U54)

Apply to Internal Competition // Limit: 1 // Tickets Available: 1

Limiting Language
Only one application per institution (normally identified by having a unique UEI number) is allowed. As defined in the HHS Grants Policy Statement, applications received in response to the same NOFO generally are scored individually and then ranked with other applications under peer review in their order of relative programmatic, technical, or scientific merit. CDC/NIOSH will not accept any application in response to this NOFO that is essentially the same as one currently pending initial peer review unless the applicant withdraws the pending application.

Purpose
 
NIOSH is seeking applications from qualified organizations for a National Center for Construction Safety and Health Research and Translation (also known as the NIOSH National Construction Center). Applicants are expected to propose multi-disciplinary approaches for impactful applied and intervention research and hazard identification and controls, to develop partnerships for implementing prevention and intervention activities, and to serve as leaders in research translation and research-to-practice for the protection of construction workers in the United States. The NIOSH National Construction Center will accomplish these goals by 1) integrating and advancing research, 2) translating and disseminating best practices, 3) disseminating information, 4) informing policy, and 5) building capacity. Applicants must describe the occupational health and safety burden(s) addressed in their proposals. In addition, they must link the need for the proposed research and related activities to the planned outputs and outcomes that will help address or alleviate the construction sector burdens described. Applicants should also describe the anticipated impacts and potential outcomes of the proposed research and related activities that will occur during the 5-year project period and beyond.

Funding Type
External Deadline
9/30/2026 (Required LOI); 10/30/2026 (Full Application)

Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed)

Request Ticket // Limit: 1 // Tickets Available: 1 

Limiting Language
Only one application per institution (normally identified by having a unique entity identifier (UEI) number or NIH IPF number) is allowed.

No institution may submit, or participate in (as a sub-award), more than one TRAC application.

NOFO Purpose
The purpose of this notice of funding opportunity (NOFO) is to support applications for the Tuberculosis (TB) Research Advancement Centers (TRACs) program. The goal of the TRACs is to develop the next generation of TB researchers and to catalyze multidisciplinary and innovative TB science by providing expertise and resources to facilitate basic and clinical TB research.

Funding Opportunity Goals 
To assist public and private nonprofit institutions and individuals to establish, expand and improve biomedical research and research training in infectious diseases and related areas; to conduct developmental research, to produce and test research materials. To assist public, private and commercial institutions to conduct developmental research, to produce and test research materials, to provide research services as required by the agency for programs in infectious diseases, and controlling disease caused by infectious or parasitic agents, allergic and immunologic diseases and related areas. Projects range from studies of microbial physiology and antigenic structure to collaborative trials of experimental drugs and vaccines, mechanisms of resistance to antibiotics as well as research dealing with epidemiological observations in hospitalized patients or community populations and progress in allergic and immunologic diseases. Because of this dual focus, the program encompasses both basic research and clinical research. 

2027 Allied World and St. Baldrick's Foundation Fellowship Awards

Request Ticket // Limit: 1* (additional application possible for cancer types specified below) // Tickets Available: 1

Limiting Language

  • Institutions may submit only one new fellowship application per year, with the exception noted in the next bullet allowing a possible second application. (Concurrent fellows with different funding periods are allowed.) 
  • ATTENTION: limited submissions policy exception:  Due to high interest from donors and low numbers of past applications, a second Fellow application will be accepted only if focused on one of the following:   
    • Brain tumors – all types, including rare forms, especially atypical teratoid/rhabdoid tumor (AT/RT), diffuse intrinsic pontine glioma (DIPG)/diffuse midline glioma (DMG), and glioblastoma (GBM) 
    • Burkitt lymphoma – all types, especially sporadic 
    • Rhabdoid tumors - Extrarenal 
  • NOTE: This exception to the limited submissions policy is valid whether or not your institution took advantage of the exception in another grant cycle. 

Program Overview/Select Eligibility Criteria
St. Baldrick’s Fellowships are granted for two (2) years of pediatric oncology fellowship training, with an opportunity for one (1) additional year of funding based upon need, significant accomplishment, and approved application. 

  • During each grant cycle, an applicant can only apply once as the lead Principal Investigator.  
  • Institutions must be located in the United States. 
  • Applicants need not be American citizens; however, they must work at an academic, medical, or non-profit research institution within the United States. 
  • Applicants from the NCI/NIH are not eligible to apply for St. Baldrick’s Fellowship Awards. 
  • For Fellowship Awards, a program/institution is defined by the institution’s American Board of Pediatrics approved fellowship program in Pediatric Hematology/Oncology.  
  • St. Baldrick’s funds may not be used for human embryonic stem cell research.
  • Fellowship Awards are limited to salary and fringe benefits for the Fellow. • Applicants should hold an M.D. or D.O. degree by the date the grant becomes effective. 
  • Applicant should be in their 2nd or 3rd year of pediatric oncology fellowship by July 1, 2027. Exceptions are allowed for a research residency format (2 years of residency 4 years of fellowship).  
    • If the applicant fits a research residency format exception, please state this in the applicant eligibility statement in the Letter of Intent. 
  • Applicants may not hold an appointment of assistant professor or above. 
  • Applicants must have a fellowship mentor who provides supervision, facilities, and research support at an American Board of Pediatrics approved fellowship program in Pediatric Hematology/Oncology. 
    • A co-mentor is allowed. 

The full request for proposals is linked here. 

Funding Type
External Deadline
7/9/2026 (LOI); 8/28/2026 (Full Proposal)
Solicitation Type

FY2026 TechLeaders: Critical Emerging Technologies Exchange

Request Ticket // Limit: 1 // Tickets Available: 1

Limiting Language 
Only one proposal will be considered by ECA from each applicant organization. In cases where more than one submission from an applicant appears in grants.gov, ECA will only consider the submission made closest in time to the NOFO deadline; that submission would constitute the one and only proposal ECA would review from that applicant.


Executive Summary
The Office of Citizen Exchanges, Global Leaders Division, of the Bureau of Educational and Cultural Affairs (ECA) invites proposal submissions for the FY 2026 TechLeaders: Critical Emerging Technologies Program. TechLeaders will strengthen America’s technological edge and industry dominance by promoting U.S. leadership in Artificial Intelligence (AI), Space Technology, Biotechnology/Health Technology, Supply Chain/Cold Chain Technology, and Agricultural Technology (AgriTech). This initiative engages approximately 60 foreign participants, ages 25-40, from Europe and Eurasia, East Asia and the Pacific, Middle East and North Africa, South and Central Asia, Sub-Saharan Africa, and the Western Hemisphere through a five-week intensive placement in the United States. Participants will collaborate with U.S.- based mentors and companies to develop actionable solutions in critical technology sectors, showcasing American expertise and innovation. The program will also feature overseas components including reciprocal exchanges and an accelerator following the second U.S.-based cohort to expand U.S. influence, inspire future STEM professionals, and foster collaboration with American businesses. TechLeaders supports U.S. national security and foreign policy objectives byexporting American expertise and technological innovations abroad, promoting U.S.- preferred technology standards globally, bolstering economic ties, and countering the proliferation of malign competitors’ technology in the global market.

Organizations applying for this federal award must demonstrate the capacity to recruit, select, and place participants, manage all program logistics, and implement overseas programming, which includes annual reciprocal exchanges and a Critical Emerging Technologies Accelerator program after the second cohort of participants. The recipient will be awarded $ 1,500,000 for the overall FY 2026 TechLeaders: Critical Emerging Technologies Program, ensuring that taxpayer dollars are used efficiently to advance U.S. national interests and global leadership in criticaltechnology sectors.